APOE and early-onset autosomal dominant Alzheimer disease: While LA and ARA are substrates for the synthesis of bioactive oxylipins, some investigators suggest ω6 DPA may improve blood lipids, i.e., LDL-C and HDL-C [64] as well as neural inflammation in an APOE-based Alzheimer’s disease model [65].